This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sun Pharma Global Fze. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Matt Callahan - Innovator in Prostate Cancer Treatment
Introduction
Matt Callahan is a notable inventor based in Penn Valley, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of prostate cancer. His innovative approach has led to the development of a unique formulation that enhances the efficacy of existing treatments.
Latest Patents
Matt Callahan holds a patent for an abiraterone steroid formulation. This nanoparticulate composition of abiraterone acetate allows for treatment at a lower dose compared to conventional abiraterone acetate formulations. The method involves administering this composition alongside a glucocorticoid to effectively treat prostate cancer.
Career Highlights
Callahan is currently associated with Sun Pharma Global Fze, where he continues to work on advancements in pharmaceutical formulations. His expertise in drug development has positioned him as a key player in the industry.
Collaborations
Throughout his career, Matt has collaborated with several professionals, including Paul Nemeth and H William Bosch. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Matt Callahan's work in developing a novel abiraterone formulation exemplifies his commitment to improving cancer treatment. His contributions are paving the way for more effective therapies in the fight against prostate cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile